NEW whitepaper: Tackling therapeutic inertia to boost patient outcomes

Read this exclusive whitepaper to gain key insights from patient experts and pharma leaders from Ipsen, Novartis, and WeFight on pharma can prevent lags in care, suboptimal patient outcomes and growing healthcare costs.

Fill in your details to access the whitepaper now >>>

Learn from experts including:

Philippe Barillon, Global Head Insights & Analytics - Cardio-Renal-Metabolic Franchise, Novartis
Mike Devoy, CMO, Executive VP, Medical Affairs & Pharmacovigilance, Bayer
Dr Oleksandr Gorbenko, Global Patient Affairs Director, Neurosciences, Ipsen
Jeanne Kehren, SVP Digital & Commercial Innovation & CIO, Bayer
Connie Montgomery, Patient advocate
Lilly Stairs, Founder & Principal, Patient Authentic
Julia Walsh, CEO, Brand Medicine International
Charlotta Norgaard, CEO and Co-Founder, Patient in Focus
Benoit Brouard, CEO and Co-founder, Wefight
Rafael Ayoub, Medical Advisor,, Wefight

Address therapeutic inertia to mitigate poor patient outcomes – download your whitepaper now >>>

Don’t hesitate to get in touch with any feedback.

Kind regards,

Reuters Events is part of Reuters News & Media Ltd, 5 Canada Square, Canary Wharf, London, E14 5AQ. Registered in England and Wales: 2505735.

Terms and conditions | Privacy Policy

Address therapeutic inertia to mitigate poor patient outcomes – download your whitepaper now

Fill in your details below to learn from patient advocates and leaders from Bayer, Ipsen, Novartis and more!

First Name*

Last Name*

Job Title*

Company*

Business Email Address*

Country*

Business Type*

I am interested in:*

Reuters Events will use this information to contact you about relevant content, products, and services. You may unsubscribe at any time. For more information, check out our Privacy Policy: https://www.thomsonreuters.com/en/privacy-statement.html.